Brimonidine and Cellcept drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Brimonidine (brimonidine) and Cellcept (mycophenolate mofetil). Common drug interactions include visual impairment among females and blood pressure systolic increased among males.
The phase IV clinical study analyzes what interactions people have when they take Brimonidine and Cellcept. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.
What is Brimonidine?
Brimonidine has active ingredients of brimonidine. It is often used in glaucoma. eHealthMe is studying from 6,276 Brimonidine users. Check the latest studies of Brimonidine.
What is Cellcept?
Cellcept has active ingredients of mycophenolate mofetil. It is often used in systemic lupus erythematosus. eHealthMe is studying from 41,872 Cellcept users. Check the latest studies of Cellcept.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
15 people who take Brimonidine and Cellcept together, and have interactions are studied.

What are the common drug interactions of Brimonidine and Cellcept, by gender? *:
female:
- Visual impairment
- Corneal thickening
- Eye pain
- Gastrointestinal disorder (functional problems of gastrointestinal tract)
- Inflammation
- Ocular hypertension (intraocular pressure higher than normal)
- Optic neuropathy (optic nerve damage)
- Photophobia (extreme sensitivity to light)
- Retinopathy (acute damage to the retina of the eye)
- Scleritis (inflammation of sclera)
male:
- Blood pressure systolic increased
- Ear pruritus (pruritus or itching is ""the unpleasant skin sensation that frequently provokes scratching"" in ear)
- Eye pain
- Visual impairment
- Drug ineffective
- Hypertension (high blood pressure)
- Adhesion
- Cataract (clouding of the lens inside the eye)
- Corneal scar (nullah)
- Death
What are the common drug interactions of Brimonidine and Cellcept, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Adhesion
- Cataract (clouding of the lens inside the eye)
- Corneal scar (nullah)
- Drug ineffective
- Dry eye (lack of adequate tears)
- Eye irritation
- Eye pain
- Impaired healing
- Intraocular pressure increased
- Photophobia (extreme sensitivity to light)
50-59:
- Drug ineffective
- Hepatitis c
60+:
- Blood pressure systolic increased
- Ear pruritus (pruritus or itching is ""the unpleasant skin sensation that frequently provokes scratching"" in ear)
- Hypertension (high blood pressure)
- Rash
- Erythema (redness of the skin)
- Infusion related reaction
- Joint swelling
- Micturition disorder (disease of passing urine)
- Oxygen saturation decreased
- Peripheral swelling
What are the existing conditions these people have? *
- Uveitis (inflammation of the uvea): 5 people, 33.33%
- Ocular Pemphigoid (inflammatory autoimmune disorder characterized by blistering lesions that affect mucous membrane covering of eye): 4 people, 26.67%
- Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 13.33%
- Immunodeficiency Disorders: 2 people, 13.33%
- Stress And Anxiety: 1 person, 6.67%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 6.67%
- Retinal Oedema (swelling of retina): 1 person, 6.67%
- Retinal Neovascularisation (development of tiny, abnormal, leaky blood vessels inside the retina): 1 person, 6.67%
- Pain: 1 person, 6.67%
- Iridocyclitis (inflammation of the iris and ciliary body of the eye): 1 person, 6.67%
* Approximation only. Some reports may have incomplete information.
Do you take Brimonidine and Cellcept?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Brimonidine (6,276 reports)
- Cellcept (41,872 reports)
Browse all drug interactions of Brimonidine and Cellcept:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Brimonidine:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Cellcept:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Brimonidine and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Cellcept and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on brimonidine and mycophenolate mofetil (the active ingredients of Brimonidine and Cellcept, respectively), and Brimonidine and Cellcept (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Mesalamine cause Hypoglycemia? - 3 seconds ago
- Drug interactions of Detrol and Lomotil - 20 seconds ago
- Exalgo vs. Humira, side effect and effectiveness comparison - 25 seconds ago
- Could Phenytoin Sodium cause Febrile Neutropenia? - 27 seconds ago
- Could Ranitidine cause Muscle Aches? - 41 seconds ago
- Drug interactions of Naproxen and Remicade - 42 seconds ago
- Stomatitis and Dizziness - a minute ago
- Drug interactions of Risedronate Sodium and Flurbiprofen - a minute ago
- Schizophrenia and Respiratory Acidosis - a minute ago
- Sickle Cell Anemia and Abdominal Pain - a minute ago